Latest filing published 01 Feb 2017 for Jounce Therapeutics, Inc., €9.3M.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Celgene Switzerland LLC: trading record in brief
This profile gathers the share dealings of Celgene Switzerland LLC in Jounce Therapeutics, Inc. In total, 2 filings cover trades dated 1 February 2017.
The open-market record is one-sided, with 1 purchase worth €9.3M and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
On 1 February 2017 came the latest disclosure, an open-market purchase for €9.3M in Jounce Therapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Celgene Switzerland LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 625,000 shares@ US$16.00100.0% of flowCommon StockSEC:0001209191-17-006676:1Canonical exit: 2 May 2017 (T+90)
- 2,831,463 sharesCommon StockSEC:0001209191-17-006676:0
2 of 2 declarations